Salix Pharmaceuticals v. Chappel
This text of Salix Pharmaceuticals v. Chappel (Salix Pharmaceuticals v. Chappel) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE SUPREME COURT OF THE STATE OF DELAWARE
SALIX PHARMACEUTICALS, LTD. § STOCKHOLDER LITIGATION § No. 308, 2016 § ROBERTA FEINSTEIN and REX § Court Below: Court of GONSALVES, § Chancery of the State of § Delaware Plaintiffs Below § Appellants, § C.A. No. 10721-CB § v. § § JOHN F. CHAPPELL, THOMAS W. § D’ALONZO, WILLIAM P. KEANE, MARK A. § SIRGO, VALEANT PHARMACEUTICALS § INTERNATIONAL, INC., VALEANT § PHARMACEUTICALS INTERNATIONAL, and § SUN MERGER SUB, INC., § § Defendants Below, § Appellees. §
Submitted: January 25, 2017 Decided: January 26, 2017
Before STRINE, Chief Justice; HOLLAND and SEITZ, Justices.
ORDER
This 26th day of January 2017, it appears to the Court that the judgment of
the Court of Chancery should be affirmed for the reasons stated in its May 19,
2016 bench ruling. NOW, THEREFORE, IT IS ORDERED that the judgment of the Court of
Chancery is hereby AFFIRMED.
BY THE COURT: /s/ Leo E. Strine, Jr. Chief Justice
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Salix Pharmaceuticals v. Chappel, Counsel Stack Legal Research, https://law.counselstack.com/opinion/salix-pharmaceuticals-v-chappel-del-2017.